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https://doi.org/10.1016/j.celrep.2021.109274SUMMARYMosaic analysis with doublemarkers (MADM) offers one approach to visualize and concomitantly manipulate
genetically defined cells in mice with single-cell resolution. MADM applications include the analysis of line-
age, single-cell morphology and physiology, genomic imprinting phenotypes, and dissection of cell-autono-
mous gene functions in vivo in health and disease. Yet, MADM can only be applied to <25% of all mouse
genes on select chromosomes to date. To overcome this limitation, we generate transgenic mice with
knocked-in MADM cassettes near the centromeres of all 19 autosomes and validate their use across organs.
With this resource, >96% of the entire mouse genome can now be subjected to single-cell genetic mosaic
analysis. Beyond a proof of principle, we apply our MADM library to systematically trace sister chromatid
segregation in distinct mitotic cell lineages. We find striking chromosome-specific biases in segregation pat-
terns, reflecting a putative mechanism for the asymmetric segregation of genetic determinants in somatic
stem cell division.INTRODUCTION
Genetic mosaic individuals contain cells of distinct genotypes.
The phenomenon of genetic mosaicism occurs naturally and is
widespread acrossmulticellular organisms. Mosaicismmay pro-
gressively emerge during life but remain silent with no obvious
phenotypes (Yizhak et al., 2019). However, mosaicism is also
associated with pathologies in humans including cancer or
many neurological disorders (Biesecker and Spinner 2013;
D’Gama and Walsh 2018). Genetic mosaic animals have been
experimentally created in a number of species, and mosaic ana-
lyses provided fundamental insights in a variety of biological sys-
tems (Xu and Rubin 1993; Rossant and Spence 1998; Lee and
Luo 1999, 2001; Yochem and Herman 2003; Zugates and Lee
2004; Zong et al., 2005; Lozano and Behringer 2007; Luo 2007;
Germani et al., 2018; Kim et al., 2019).
One powerful application inherent to induced genetic mosaics
is the ability to alter gene function at a high spatiotemporal res-
olution. A certain tissue can contain homozygous mutant cells
for a gene of interest and wild-type cells whose phenotypes
can be compared with each other directly. If the genetic mosaic
is sparse, even essential genes can be manipulated without
affecting the overall health or viability of the animal. Furthermore,
sparse genetic mosaics provide a highly effective means with
which to study the causal relationship of genetic alteration andThis is an open access article under the CC BY-Nphenotypic manifestation at the individual cell level. Genetic mo-
saics also facilitate the analysis of cell competition and provide
an assay to create models of disease. Genetic mosaics have
been most extensively generated in the fruit fly by capitalizing
upon mitotic recombination between homologous chromo-
somes (Morgan and Bridges 1919; Stern 1936; Hotta and Benzer
1970; Xu and Rubin 1993; Lee and Luo 1999, 2001; Zugates and
Lee 2004). Although technically slightly more challenging, the
generation of genetic mosaics in mice is becoming routine. A
number of experimental approaches have been established
including mosaic analysis with double markers (MADM) that is
also based on mitotic recombination (Zong et al., 2005; Luo
2007; Tasic et al., 2012; Hippenmeyer 2013).
MADM relies onCre/loxP-mediated interchromosomal recom-
bination to simultaneously generate homozygous mutant cells
for a candidate gene of interest and wild-type cells in an other-
wise heterozygous background. The induction of genetic
mosaicism can be spatiotemporally controlled by the use of
cell-type-specific Cre/ER driver lines (Zong et al., 2005; Hippen-
meyer et al., 2013; Ali et al., 2014; Beattie et al., 2020). Concur-
rent to the generation of genetic mosaicism, two split genes,
encoding green fluorescent protein (GFP) and tdTomato (tdT)
fluorescent markers, are reconstituted that permit unequivocal
tracing of individual cellular phenotypes in the homozygous








Figure 1. Extension of MADM to all 19 mouse autosomes
(A) Summary of the MADMprinciple. For MADM, two chimeric split marker genes containing partial coding sequences of EGFP and tdT are inserted into identical
genomic loci of homologous chromosomes. Following Cre-recombinase-mediated interchromosomal (trans) recombination during mitosis, the split marker
genes are reconstituted and functional green and red fluorescent proteins expressed. As a result, green GFP+, red tdT+, and yellow GFP+/tdT+ cells appear
sparsely, due to an inherently low stochastic interchromosomal recombination rate, within the genetically defined cell population expressing Cre recombinase.
Introduction of a mutant allele distal to the MADM cassette results in a genetic mosaic with homozygous mutant cells labeled in one color (e.g., green GFP+) and
homozygous wild-type sibling cells in the other (e.g., red tdT+). Heterozygous cells appear in yellow (GFP+/tdT+).
(B) Expansion of MADM to all mouse autosomes. Transgenic mice with MADM cassettes inserted close to the centromere have been generated for all 19 mouse
autosomes. The directionality (forward, centromere-telomere; reverse, telomere-centromere) of marker gene transcription is indicated.
(C) MADM labeling scheme for cassettes inserted in forward direction. MADM experiments involving forward cassettes require that the mutant allele of a
candidate gene must be linked to the T-G MADM cassette in order for mutant cells to be labeled in green upon a G2-X MADM event.
(D) MADM labeling scheme for cassettes inserted in reverse direction. MADM experiments involving reverse cassettes require that the mutant allele of a
candidate gene must be linked to the G-T MADM cassette in order for mutant cells to be labeled in green upon a G2-X MADM event.
(E) Generation of recombinant MADM chromosomes. To genetically link a mutant allele of a candidate gene of interest to the corresponding chromosome
containing the T-G MADM cassette (i.e., forward orientation), it is necessary to first cross mice bearing the T-G MADM cassette with mice bearing the mutant
allele. Resulting F1 transheterozygous offspring are then backcrossed to mice homozygous for the T-G MADM cassette. In F2, recombinant offspring emerge
from meiotic recombination events in the germline. These F2 recombinants now contain both the MADM cassette (in homozygous configuration) and the mutant
(legend continued on next page)






OPEN ACCESSin distinct colors with 100% accuracy (Zong et al., 2005; Hippen-
meyer et al., 2010; Figure 1A; Figure S1).
The MADM approach enables unparalleled lineage tracing,
and MADM-labeled cells can be assessed by histological
means, physiological analysis, and optical imaging in vivo (Espi-
nosa et al., 2009; Hippenmeyer et al., 2010; Liang et al., 2013;
Gao et al., 2014; Joo et al., 2014; Riccio et al., 2016; Beattie
et al., 2017; Henderson et al., 2019; Lv et al., 2019; Ortiz-Álvarez
et al., 2019).
MADM technology represents one approach to probe
genomic imprinting and the function of imprinted genes (Hippen-
meyer et al., 2013; Laukoter et al., 2020b). MADM can be applied
to create uniparental chromosome disomy (UPD; somatic cells
with two copies of either the maternal or paternal chromosome)
and visualize imprinting effects at morphological and transcrip-
tional levels with single-cell resolution (Hippenmeyer et al.,
2013; Laukoter et al., 2020a, 2020c).
One clinically relevant application ofMADM is the tracing of tu-
mor growth upon sparse or clonal ablation of tumor suppressor
genes and/or to assay for the effects of therapeutic agents. As
such, MADM has been used for the analysis of tumor formation
and the delineation of cancer cell of origin at the single-cell level
in the brain and distinct organs (Muzumdar et al., 2007, 2016; Liu
et al., 2011; Gonzalez et al., 2018; Tian et al., 2020; Yao et al.,
2020).
A current limitation of the MADM technology is that it can only
be applied to study candidate genes located on chromosome 7
(chr7), chr11, and chr12 and distal to the Rosa26 locus on chr6,
whereMADMcassettes have been introduced (Zong et al., 2005;
Hippenmeyer et al., 2010, 2013). Thus, less than 25%of all genes
in the mouse genome can be subjected to MADM analysis as
described above. Here, we overcome this constraint and expand
MADM technology to all mouse autosomes. We provide valida-
tion of all MADM reporters and quantitative assessment of the ef-
ficacy of MADM labeling in a variety of organs and tissues and a
number of clinically relevant stem cell niches across the entire
mouse. Furthermore, we use engineered MADM chromosomes
to systematically determine sister chromatid segregation pat-
terns in several somatic cell lineages. Our analysis revealed
that sister chromatid segregation patterns in mitotic progenitor
cell divisions are highly biased in a chromosome-specific
manner and are further affected by cell type in vivo.
RESULTS
Expansion of MADM to all mouse autosomes
For MADM, two reciprocally chimeric marker genes need to be
targeted to identical loci on homologous chromosomes (Zong
et al., 2005). The chimeric marker genes (GT and TG alleles)
consist of N- or C-terminal halves of the coding sequences for
GFP (enhanced GFP) and red fluorescent protein (tdT) inter-
spersed by an intron with the loxP site (Hippenmeyer et al.,allele linked on the same chromosome. For experimental MADMmice, F2 recomb
of interest.
(F) Calculation of predicted meiotic recombination frequency. The probability for
mutant allele can be estimated by the genetic distance of the MADM cassette to
See also Figures S1–S4 and Table S1.2010; Figure 1A; Figure S1). Here, we expanded MADM to all
19 mouse autosomes with the goal to enable MADM for the
vast majority, nearly genome-wide, of autosomal genes in the
mouse genome. Mouse autosomes consist of only one chromo-
some arm (i.e., telocentric conformation). We thus rationalized
that inserting the MADM cassettes as close as possible to the
centromere would maximize the number of genes located
distally to the MADM cassette insertion site for prospective
MADM experiments (Hippenmeyer et al., 2010, 2013; Figures
1A and 1B).
To identify suitable sites for MADM cassette targeting, we
applied a number of key criteria. The loci should (1) locate to
intergenic regions tominimize the probability of disrupting endog-
enous gene function and (2) permit spatially and temporally ubiq-
uitous and biallelic expression of the reconstituted GFP and tdT
markers. To fulfill the first criteria, we mapped gene by gene
the genetic landscape of the centromeric-most 20 Mbp of all
autosomes using the UCSC Genome Browser (https://www.
genome.ucsc.edu; GRCm38/mm10). Next, we assessed EST
(expression sequence tag) expressionpatterns of the neighboring
genes flanking the putative targeting sites and serving as proxy
for the spatiotemporal extent of transgene expression. The final
choice of the prime targeting loci (Figure 1B; Figures S2 and
S3; Table S1) was based upon the most ideal combination of
the above key criteria. In total, more than 20,000 protein-coding
genes, corresponding to >96% of the entire annotated mouse
genome (GRCm38/mm10), are located distally to the MADM tar-
geting loci across all 19 autosomes (Table S1).
Next, we cloned the selected genomic targeting loci and in-
serted the MADM cassettes (Hippenmeyer et al., 2010) by ho-
mologous recombination in mouse embryonic stem cells
(ESCs) (Figure S4; see STAR Methods for details). MADM cas-
settes were inserted in a centromere-to-telomere transcriptional
direction (Figure 1B, forward) except for chr3, chr5, chr6, and
chr15, which required opposite directionality (Figure 1B, reverse)
in order to best fulfill our locus choice criteria. The directionality
of reconstituted MADM marker gene transcription, upon
interchromosomal recombination, has consequences for the
coupling of mutant and wild-type genotypes with fluorescent la-
beling upon mitosis (Figures 1C and 1D). In order to genetically
link a mutant allele of a candidate gene to the corresponding
chromosome containing the MADM cassette, meiotic recombi-
nation in the germline can be used (e.g., Hippenmeyer et al.,
2010; Laukoter et al., 2020b; (Figures 1E and 1F). The probability
for meiotic recombination that results in the linkage of themutant
allele with theMADMcassette can be estimated (Figure 1F) once
the location (cM) of the mutant allele (genomic locus) has been
determined by using, for example, the Mouse Genome Infor-
matics (MGI) database (https://www.informatics.jax.org).
Homologous recombination frequencies in ESCs were rela-
tively high for all selected loci (for some, >50%), hinting at an
open chromatin structure that should be an advantage forinants are crossed with mice bearing the G-T MADM cassette and a Cre driver
meiotic recombination resulting in the linkage of the MADM cassette with the
the location of the mutant allele divided by two.
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Figure 2. MADM labeling pattern in different organs and stem cell niches
(A) Overview of MADM labeling (green, GFP; red, tdT; yellow, GFP/tdT) inMADM-19GT/TG in combination with Hprt-Cre at P21. Diverse tissues/organs including
eye, brain, lung, spinal cord, kidney, spleen, liver, heart, and thymus are illustrated.
(legend continued on next page)






OPEN ACCESSprospective mitotic Cre-mediated interchromosomal recombi-
nation. Next, chimeric founder mice were generated by blasto-
cyst injection. Homozygous MADMGT/GT and MADMTG/TG stock
lines were established upon successful germline transmission of
the respective MADM cassettes (Figure S4) by using specific
genotyping primers (Table S2).
Ubiquitous labeling in all MADM reporter lines across
different organs
We systematically analyzed the MADM labeling pattern upon
Cre-mediated interchromosmal recombination in all MADM lines
(Figure S4E). First, we crossed all MADMGT/GT lines to mice that
carry the Cre transgene within the X-linked Hprt (encoding hypo-
xanthine guanine phosphoribosyl transferase) genomic locus.
The Hprt-Cre driver is spatiotemporally ubiquitously and consti-
tutively expressed (Tang et al., 2002). In femalemice, inactivation
of the X chromosome results in mosaic Cre expression from the
Hprt locus and thus highly variable MADM labeling patterns
(Zong et al., 2005; Hippenmeyer et al., 2013). We therefore
analyzed male experimental MADM (MADMGT/TG;HprtCre/Y) ani-
mals for a first pass comparative assessment. We detected
MADM labeling in all organs analyzed—including brain, spinal
cord, eye, heart, lung, liver, kidney, thymus, and spleen (Fig-
ure 2A)—and in all MADM lines. The relative recombination fre-
quency, at least at this superficial qualitative level, appeared to
correlate in distinct selected organs across all 19 MADM lines
(Figures 2 and S5–S9).
MADM labeling in clinically relevant adult stem cell
niches
We next evaluated a number of stem cell niches with high clinical
relevance. Because it is important to know the approximate
scale of labeling for determining sample size in a MADM exper-
iment, we chose two different MADM models in combination
with Hprt-Cre driver for these analyses, as follows: MADM-19
that shows relatively dense MADM labeling and MADM-4 that
represents one of the sparsest MADM.
First, we focused on the mammary gland (Figure 2B), the site
where breast cancer initiates. The mammary gland harbors two
typesofunipotent stemcell lineages, namely, theK14+myoepithe-
lial (or basal) cells and the K8+ luminal cells (Van Keymeulen et al.,
2011). Myoepithelial and luminal stem cell populations are derived
from a multipotent progenitor during embryonic development
(Wuidart et al., 2018), become unipotent at birth, and can both
give rise to mammary tumors upon transformation. We evaluated
the MADM-labeling pattern in the postnatal mammary gland in(B) Schematic (left) and MADM labeling (middle/right; green, GFP; red, tdT; yellow
4 months of age. Basal/myoepithelial (middle) and luminal (right) cells are stained
(C) Schematic (left) MADM labeling (right; green, GFP; red, tdT; yellow, GFP/tdT)
are visualized by antibody staining against b-catenin (white; b-Cat). Acinar cells
(D) Schematic (left) and MADM labeling (middle/right; green, GFP; red, tdT; ye
19GT/TG;HprtCre/+ at P21 (telogen) and P28 (anagen). Bu, bulge; 2 HG, secondary
ORS, outer root sheath; Mx, matrix.
(E) Schematic (left) and MADM labeling (right; green, GFP; red, tdT; yellow, GFP
visualized by antibody staining against b-catenin (white; b-Cat). Asterisk marks a
amplifying cell; LGR5, leucine-rich repeat-containing G-protein coupled recepto
Nuclei were stained using DAPI. Scale bar: 50 mm (A) and 20 mm (B–E).
See also Figures S5–S8.adult lactating 4-month-old femaleMADM-19GT/TG;HprtCre/+ (Fig-
ure 2B) and MADM-4GT/TG;HprtCre/+ (Figure S7A) mice and could
readilydetectGFP+ (green), tdT+ (red),andGFP+/tdT+ (yellow)cells
in both K14+ basal and K8+ luminal cells.
Next, we analyzed pancreatic epithelial cells that can be
divided into secretory acinar cells and ductal epithelial cells.
Although the tumor cell of origin for pancreatic cancer remains
controversial, oncogenic drivers can trigger pancreatic ductal
adenocarcinoma (PDAC) from both ductal and acinar cells
(Ferreira et al., 2017; Lee et al., 2019). In both, MADM-
19GT/TG;HprtCre/+ and MADM-4GT/TG;HprtCre/+ mice at postnatal
day 21 (P21), we noticed MADM-labeled cells in the acinus
and duct within the pancreas (Figure 2C and S7B).
Hair follicles are a prime stem cell model for the study of tissue
regeneration but also for skin cancer including melanoma (Sun
et al., 2019). Hair follicles are appendages of the epidermal line-
age and undergo cycling rounds of stem cell activation in order to
generate new hair (Fuchs and Nowak 2008). The stem cells are
located in the secondary hair germ (2 HG) and lower part of
the bulge (Bu) of a resting follicle (telogen follicle) (Figure 2D).
They become activated, start to proliferate, and expand the
hair follicle deep down into the dermis. Progenitors located at
the bottom of the activated follicle (anagen follicle) form the ma-
trix, from where epithelial hair lineages are specified (Hsu et al.,
2014). Such differentiated hair lineages comprise the companion
layer (CP), distinct layers of inner root sheath (IRS), and cuticle
and cortex of the hair shaft (HS), as well as the innermost hair
layer the medulla (Me). Once hair regeneration is completed,
the follicles undergo a destructive phase (catagen) and enter
the quiescent resting phase again. In the skin ofMADM-19GT/TG;
HprtCre/+ and MADM-4GT/TG;HprtCre/+ mice, we observed prom-
inent MADM labeling in all compartments of the hair follicle
and importantly in the hair follicle stem cells (Figures 2D
and S7C).
Next, we analyzed MADM labeling in the small intestine that
represents another critical model for the study of stem-cell-
mediated regeneration but also intestinal cancer (Barker et al.,
2009). Intestinal stem cells replenishing the epithelium are
LGR5+ and located in the crypt base (Barker et al., 2007). They
are intermingled with secretory Paneth cells and divide
constantly in order to rejuvenate the epithelial cell layer on the vil-
lus surface. Interestingly, LGR5+ stem cells mostly divide sym-
metrically and undergo neutral competition within the crypt,
thus driving the crypt toward monoclonality (Snippert et al.,
2010). In order to evaluate the potential for MADM-based lineage
tracing, the study of loss of gene function, and analysis of stem, GFP/tdT) in mammary gland of lactating MADM-19GT/TG;HprtCre/+ female at
with antibodies against K14 and K8 (white), respectively.
in MADM-19GT/TG;HprtCre/+ pancreas, acinus, and duct, at P21. Epithelial cells
are identified by the presence of intracellular secretory granules.
llow, GFP/tdT) in telogen (middle) and anagen (right) hair follicles in MADM-
hair germ; SG, sebaceous gland; IRS, inner root sheath; CP, companion layer;
/tdT) in small intestine in MADM-19GT/TG;HprtCre/+ at P21. Epithelial cells are
Paneth cell, identified by the presence of intracellular granules. TAC, transit-
r 5.
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OPEN ACCESScell behavior in the intestinal crypts, we dissected the intestine of
MADM-19GT/TG;HprtCre/+ and MADM-4GT/TG;HprtCre/+ mice at
P21. We observed MADM-labeled cells in all compartments of
the intestinal unit, including the villus and the crypt (Figure 2E
and S7D).
Lastly, we validated one of the MADM reporters in a disease-
relevant setting. We used MADM-18 lines to examine the effect
of clonal loss of Apc (adenomatous polyposis coli). APC func-
tions as a tumor suppressor and mutations in APC cause
hereditary and sporadic human bowel cancers upon loss of het-
erozygosity (Behrens et al., 1998; Fodde et al., 2001). To mimic
the intestinal tumor initiation, we generated genetic mosaic
mice harboring green Apc/ cells by using an Apc-flox allele
(Cheung et al., 2010) and red wild-type cells in an otherwise
heterozygous environment (Figure 3). At 3 months of age,
MADM-18GT/TG;HprtCre/+ control mice showed several red- or
green-labeled normal crypt-villus units (Figures 3A–3D). Note
that MADM labeling within crypt-villus units appeared exclu-
sively unicolor, reflecting monoclonality due to stochastic
competition between dividing intestinal stem cells (Snippert
et al., 2010). In contrast, all MADM-18GT/TG,Apc;HprtCre/+ experi-
mental mice, in which Apc–/– cells are labeled in green and
Apc+/+ cells in red by design, displayed one or several green-
labeled cancerous lesions (adenomas), derived from Apc/
stem cells, in their small intestine and colon (Figures 3E–3G;
Barker et al., 2009). Yet, we did not detect any tumors derived
from red control cells in MADM-18GT/TG,Apc;HprtCre/+ experi-
mental mice (Figure 3D). Antibody staining against phosphohi-
stone H3 (P-H3) confirmed that normal crypt-villus units display
proliferation only within the crypt compartment but not within the
villus epithelium (Figures 3B, 3C, and 3F). In contrast, adenomas
derived from green Apc/ cells in mosaic mice contained prolif-
erating tumor cells in regions outside the crypt compartment
(Figure 3F) as previously reported (Schepers et al., 2012). In sum-
mary, we validated one of the MADM lines for functional genetic
mosaic analysis in the context of the Apcmodel (Figures 3H and
3I) for tumor initiation and growth.
Genomic imprinting phenotypes in liver cells with UPD
MADM can create UPD (Figure 4A) to analyze imprinting pheno-
types at the single-cell level that result from the imbalanced
expression of imprinted genes (Hippenmeyer et al., 2013; Lau-
koter et al., 2020b, 2020c; Pauler et al., 2021). Prominent
imprinting phenotypes have been observed in the liver where,
for instance cells with MADM-induced paternal UPD of chr7
exhibit overgrowth (Hippenmeyer et al., 2013), in accordance
with the kinship hypothesis that stipulates a major growth regu-
latory function of genomic imprinting (Haig 2004; Tucci et al.,
2019). Because imprinted genes are located throughout the
genome, we analyzed the liver in all 19 MADM reporters in com-
bination with Hprt-Cre (Figures 4B–4U) for potential imprinting
phenotypes. We readily observed the growth advantage of he-
patocytes with paternal UPD of chr7 (Figures 4H and 4V) but
also noticed that cells with paternal UPD of chr11 (Figures 4L
and 4V) and chr17 (Figures 4R and 4V) showed significant over-
representation in comparison to cells with maternal UPD. The
maternally expressed growth inhibitory imprinted genes Grb10
and Igf2r are located on chr11 and chr17, respectively. Thus,6 Cell Reports 35, 109274, June 22, 2021although overexpression of growth-promoting Igf2 in UPD of
chr7 leads to paternal growth dominance (Hippenmeyer et al.,
2013), the absence of growth-antagonizingGrb10 or Igf2r (Smith
et al., 2006) may result in the growth advantage of cells with
paternal UPD of chr11 or chr17. We did not find significant
UPD-mediated phenotypes in the liver of any other MADM (Fig-
ures 4B–4U).
Quantification of recombination efficiency of all MADM
chromosomes
To systematically determine recombination frequencies
comparatively in all MADMs, we quantified the absolute density
of MADM-labeled neurons in the neocortex of P21mice by using
the Emx1-Cre driver (Figures 5A, 5B, and S9). We first assessed
MADM labeling originating from G2-X events and quantified the
numbers of green GFP+ and red tdT+ projection neurons per cu-
bic millimeter (Figures 5A and 5B). The relative number of red
tdT+ versus green GFP+ projection neurons was not significantly
different across MADM lines (Figures 5B; Table S3). We classi-
fied the MADM reporters into three categories, as follows: (1)
sparse (<25 cells/mm3), (2) intermediate (25–100 cells/mm3),
and (3) dense (>100 cells/mm3). Because all MADM-targeting
loci have been selected by using the same criteria, the origin of
the variability in recombination frequency across all MADMs is
currently not clear. In mice, the pairing of homologous chromo-
somes in somatic cells is infrequent and under tight regulation,
unlike in the fruit fly Drosophila (Apte and Meller 2012). Thus,
the individual dynamic organization of different homologous
chromosomes within the nucleus may result in distinct probabil-
ities of Cre-mediated interchromosomal recombination. It is also
important to mention that insertion of the MADM cassettes at
more distal locations in the same chromosome could lead to a
distinct recombination probability. In any case, all MADM re-
porters do work as predicted from the MADM principle (Figures
1 and S1) in all organs analyzed (Figures 2, 3, 4, 5, and S5–S9).
Importantly, even the sparsest MADM lines (including MADM-4
[Hansen and Hippenmeyer, unpublished observation] and
MADM-6 [Takeo et al., 2021]) reliably permit functional genetic
mosaic analysis of candidate genes.
MADM reveals chromosome-specific biases in mitotic
sister chromatid segregation patterns
Previous in vitro studies have used mitotic recombination in
ESCs tomonitor the randomness of sister chromatid segregation
patterns uponmitosis (Liu et al., 2002; Armakolas and Klar 2006).
Against common belief, initial results indicated that sister chro-
matids derived from a homologous pair of chromosomes did
not segregate randomly to daughter cells. Instead, G2-X segre-
gation (two recombinant chromosomes segregate away from
each other), thus reflecting one particular pattern of sister chro-
matid segregation, prevailed in ESCs for chr7 (Liu et al., 2002).
Furthermore, ESC-derived endoderm cell lines exhibited com-
plete bias toward G2-X (Armakolas and Klar 2006). Conversely,
ESC-derived neuroectoderm cell lines never showed G2-X (Ar-
makolas and Klar 2006). Although these results indicated that
cell type may influence the selective segregation of sister chro-
matids, such a hypothesis is based on the analysis of only one









Figure 3. Apc-tumor model at single-cell resolution using the MADM-18 line
(A) Schematic representation of MADM labeling (green, GFP; red, tdT) and respective cellular genotypes in wild-type MADM-18GT/TG;HprtCre/+ mice.
(B and C) P-H3 staining (white) in small intestine inMADM-18GT/TG;HprtCre/+ mice at 3months of age. (B) Overview of unicolor (monoclonal) green wild-type crypt-
villus units with insets highlighting non-proliferative villus epithelium (i) and a proliferative cell within the crypt (white arrow) (ii); (C) overview and unicolor
(monoclonal) red wild-type crypt-villus units with insets highlighting non-proliferative villus epithelium (iii) and a proliferating cell within the crypt (iv).
(D) Quantification of the percentage of intestinal structures displaying MADM labeling. Data obtained from n = 3 maleMADM-18GT/TG;HprtCre/+ mice at 3 months
of age.
(E) Schematic representation of MADM labeling (green, GFP; red, tdT) and respective cellular genotypes in genetic mosaic MADM-18GT/TG,Apc;HprtCre/+ mice.
(F) P-H3 staining (white) in small intestine in maleMADM-18GT/TG,Apc;HprtCre/+ mice at 3 months of age with insets highlighting a proliferating adenoma cell at the
boundary to the non-proliferative villus epithelium (white arrow) (i), proliferating adenoma cells within the tumor (white arrows) (ii), non-proliferative normal villus
epithelium (iii), and proliferative cells within a normal crypt compartment (iv).
(G) Quantification of the percentage of intestinal structures displaying MADM labeling. Green Apc/ cells display 100% transformation and tumor initiation,
whereas red wild-type cells solely give rise to normal crypt-villus-units. Data obtained from n = 3 male MADM-18GT/TG,Apc;HprtCre/+ mice at 3 months of age.
(H and I) Summary of MADM labeling in small intestine of controlMADM-18GT/TG;HprtCre/+ (H) and genetic mosaicMADM-18GT/TG,Apc;HprtCre/+ mice (I). Note that
in the mosaic, red wild-type cells give rise to normal crypt-villus units and green Apc/ cells initiate tumor development and subepithelial invasion of adenomas.
Nuclei were stained using DAPI. Scale bar: 100 mm (B, C, and F) and 25 mm (i–iv).
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OPEN ACCESStissue. To this end, we used the entire library of MADM-rendered
homologous chromosomes to systematically trace sister chro-
matid segregation patterns of all 19 mouse autosomes in a num-
ber of somatic cell lineages in vivo.
We exploited the inimitable feature provided by the MADM
principle (Figures 5C and S1)—the differential fluorescent label-
ing of pairs of nascent sister cells uponmitosis that is dependent
on how recombinant chromosomes segregate during cell divi-
sion. G2-X segregation of recombinant MADM chromosomes
can be unambiguously identified by the presence of red and
green cells. However, G2-Z segregation, producing yellow cells,
cannot be identified without ambiguity because G1 and/or
postmitotic G0 events also result in yellow cells (Zong et al.,
2005; Figures 5C and S1). Therefore, we capitalized upon the po-
wer of unequivocal G2-X identification—but also taking into
consideration the caveat of yellow cells potentially reflecting a
mix of G2-Z and G1/G0—and defined ‘‘yellow-green-red-index’’
(YGRI) as a proxy for sister chromatid segregation patterns
(Figure 5D).
First, we systematically determined the YGRI of pyramidal
projection neurons in the P21 neocortex for all 19 MADM re-
porters in combination with the Emx1-Cre driver (expressed in
cortical progenitor cells and thereby limiting G0 events) (Fig-
ure 5E; Table S3). Contrary to the prediction and expectation
based on cell culture data (no G2-X in neuroectodermal lineage
[Armakolas and Klar 2006]), we always observed G2-X events.
Interestingly, the YGRI values ranged from 1 for MADM-2
and MADM-17 to 10 for MADM-15 (Figure 5E, top). The values
of the YGRI did not correlate with the sizes of the respective
MADM chromosomes. Next, we compared the values of the
YGRI with the absolute recombination frequencies (RFI, recom-
bination frequency index), i.e., density of G2-XMADM labeling as
indicated in Figure 5B. In the ranking plot in which the axes
indicate YGRI versus RFI, therewas no apparent correlation (Fig-
ure 5E, bottom) of YGRI with RFI. In summary, we detected high-
ly distinct YGRI for different MADM chromosomes, suggesting
distinct sister chromatid segregation patterns in the cortical
Emx1+ projection neuron lineage.
Previous studies implicated left-right dynein (LRD)—the only
protein thus far in amammalian cell culture system—in the selec-
tive sister chromatid segregation process (Armakolas and KlarFigure 4. MADM-induced uniparental chromosome disomy (UPD) resu
(A) MADM scheme for imprinted genes. G2-X MADM events generate differenti
maternal [matUPD] or the paternal [patUPD] chromosome). (Top) The GTMADM c
the father (P, blue), and green cells show patUPD (PP) and red cells matUPD (MM
twice the normal dose and paternally expressed genes are not expressed in cells
by factor two and maternally expressed genes are not expressed in cells with pat
father and TG MADM cassette inherited from mother. Here, cells with matUPD a
(B–U) Representative images of horizontal liver cryosections withMADM labeling (
Hprt-Cre driver at P21. Higher resolution image (U) represents inset in (T) in left l
(V) (Top) Representative images (left, middle) of liver inMADM-7GT/TG;HprtCre/+wit
GFP+ matUPD (middle) at P21; and quantification (right) of absolute (cells/mm
Representative images (left, middle) of liver inMADM-11GT/TG;HprtCre/+ with green
matUPD (middle) at P21; and quantification (right) of absolute (cells/mm3) and r
sentative images (left, middle) of liver in MADM-17GT/TG;HprtCre/+ with green GF
matUPD (middle) at P21; and quantification (right) of absolute (cells/mm2) and rel
using DAPI. Bars represent mean ± SEM. Data show MADM-7GT/TG;HprtCre/+ n =
Scale bar: 200 mm.2007). Intriguingly, mutations in the gene (Dnah11) encoding
LRD causes randomization of left-right laterality in mice (half of
the animals develop with mirror-imaged visceral organs) (Hum-
mel and Chapman 1959; Supp et al., 1997). Based on the above
findings from cell culture, we next assessed whether Dnah11
could play a role in biased chromosome-specific sister chro-
matid in vivo as well. We crossed the MADM system to iv (situs
inversus) (a spontaneous mutation in Dnah11 [Hummel and
Chapman 1959]) background and analyzed YGRI of chr7,
chr12, and chr18 in cortical Emx1+ projection neurons (Fig-
ure 6A). However, contrary to the in vitro data (Armakolas and
Klar 2007), we could not observe randomization (i.e., a drop of
YGRI value to 1) of sister chromatid segregation for the three
tested chromosomes (chr7, chr12, and chr18). These data
suggest that cultured differentiated ESC lineages and cortical
excitatory neurons in vivo differ in mechanisms of biased sister
chromatid segregation.
Chromosome-specific biases of sister chromatid
segregation differ in distinct cell types
To determine the possible influence of cell type on biased, chro-
mosome-specific, sister chromatid segregation patterns, we first
analyzed Emx1+ cortical astrocytes and hippocampal CA1 pyra-
midal cells. The YGRI for cortical astrocytes was markedly
different from the YGRI for cortical projection neurons or hippo-
campal CA1 pyramidal cells for a representative set of 10 MADM
chromosomes analyzed (Figures 6B and 6C). Next, we intro-
duced Nestin-Cre to label neural lineages beyond forebrain
projection neurons and astrocytes. We focused on cerebellar
Purkinje cells and determined the YGRI. Strikingly, the YGRI
for Purkinje cells was also markedly different in most MADMs
compared to the YGRIs for cortical projection neurons and astro-
cytes and hippocampal CA1 pyramidal cells (Figures 6B and 6C).
Finally, we assessed sister chromatid segregation patterns for
a non-neural somatic cell type.We focused on T cells (CD3+) and
B cells (CD19+) within the hematopoietic lineage and determined
the YGRI for six different MADM chromosomes by fluorescence-
activated cell sorting (FACS) analysis (Figure 6D). Although the
distinct MADM chromosomes showed different YGRI values,
the YGRI for T cells in comparison to B cells was not significantly
different for all six chromosomes analyzed. No significantlts in paternal growth dominance in liver
ally labeled cells with near-complete UPD (cells with two copies of either the
assette is inherited from the mother (M, pink) and the TGMADM cassette from
). In such a scenario, imprinted maternally expressed genes are expressed at
with matUPD (red). In contrast, paternally expressed genes are overexpressed
UPD (green). (Bottom) Reverse scheme with GT MADM cassette inherited from
re labeled in green and cells with patUPD in red fluorescent color.
GFP, green; tdT, red) in MADM-1 (A) to MADM-19 (T and U) in combination with
ateral lobe of liver in MADM-19.
h green GFP+ patUPD and red tdT+matUPD (left) or red tdT+ patUPD and green
3) and relative (PP/MM) numbers of MADM-labeled cells with UPD. (Middle)
GFP+ patUPD and red tdT+ matUPD (left) or red tdT+ patUPD and green GFP+
elative (PP/MM) numbers of MADM-labeled cells with UPD. (Bottom) Repre-
P+ patUPD and red tdT+ matUPD (left) or red tdT+ patUPD and green GFP+
ative (PP/MM) numbers of MADM-labeled cells with UPD. Nuclei were stained
6, MADM-11GT/TG;HprtCre/+ n = 5, MADM-17GT/TG;HprtCre/+ n = 6 mice.
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OPEN ACCESScorrelation could be established when the YGRI of T/B cells was
compared to the YGRI of the neural lineages. Altogether, these
data indicate that the highly biased and chromosome-specific
sister chromatid segregation patterns are further affected by
cell type in somatic cell lineages in vivo.
DISCUSSION
The analysis of gene function in multicellular systems in vivo re-
quires quantitative and high-resolution experimental tools to
analyze the cellular phenotype. Here, we expanded the MADM
technology to enable, in principle, the genetic mosaic dissection
of cell-autonomous gene function of most genes (>96%) across
the entire mouse genome with single-cell resolution. Although
functional genetic mosaic analysis clearly represents the most
salient utility of MADM, we also extended the application spec-
trum and used MADM as a proxy to trace the randomness of
mitotic sister chromatid segregation patterns upon somatic
stem cell division. We first discuss these biological findings in
a more general context before we elaborate on the overarching
potential of the genome-wide MADM resource for future genetic
mosaic analysis.
Non-random mitotic sister chromatid segregation in
mouse in vivo
Asymmetric stem cell division requires the non-equivalent distri-
bution of cell-fate determinants including proteins, mRNA, or
intracellular organelles (Gönczy 2008; Knoblich 2008; Taverna
et al., 2014). Recently, an intriguing model has been postulated
whereby asymmetric cell division might also be promoted by dif-
ferentiation of sister chromatids by epigenetic means, followed
by selective segregation of ‘‘unequal’’ sister chromatids to
daughter cells (Bell 2005; Armakolas et al., 2010; Yamashita
2013). However, experimental evidence supporting such a
model in mice was so far obtained solely from in vitro studies
in ESCs and derived lineages and only for one chromosome
(chr7; Figure 7, left; Liu et al., 2002; Armakolas and Klar 2006).
In our study we systematically traced sister chromatid segrega-
tion patterns of the entire set of mouse autosomes in vivo. We
observed that the prevalence of G2-X events, approximated inFigure 5. Mitotic interchromosomal recombination efficiency and siste
projection neurons
(A) Representative images of MADM-labeling pattern (green, GFP; red, tdT; yello
with the Emx1-Cre driver at P21. (Top) MADM-9GT/TG;Emx1Cre/+; (middle) MADM
(B) Classification ofMADM lines. (Top) Sparse (< 25 cells/mm3). (Middle) Intermedi
± SEM. Data show M7, M11, and M19 (n = 5); M2, M3, M5, M8–M10, and M12–
(C) MADM principle illustrating G2-X and G2-Z segregation patterns. Upon Cre-
settes in G2 phase of the cell cycle, recombinant chromosomes can either segreg
unlabeled cell) or each recombinant chromosome may segregate to distinct daug
mitosis.
(D) Definition of yellow-green-red-index index (YGRI). The YGRI is calculated fro
compensate for G2-Z events that leads to labeling of only one daughter cell (yello
events contribute to the total number of yellow cells.
(E) YGR index in neuronal lineages. (Top) YGRI for cortical projection neurons in P
driver. Note that (1) YGRI varies from 1 to 10 but is never below 1 and (2) YGRIs
represent mean ± SEM. Data show M2, M3, M5, and M7–M19 (n = 6); M4 and
recombination frequency index (RFI). Note that MADM chromosomes with a high
See also Figures S1 and S9.the value of YGRI, in the same cell type (cortical projection neu-
rons) and by using identical an Emx1-Cre driver vastly differed,
up to one order of magnitude for different chromosomes. How-
ever, the relative amount of G2-X segregation did not correlate
with the absolute recombination frequency. Thus, high absolute
recombination frequency does not predict a bias in recombinant
sister chromatid segregation toward G2-X nor G2-Z. Previous
work has postulated that it is highly unlikely that biased sister
chromatid segregation may have evolved for a site-specific
recombination system not indigenous tomouse cells (Armakolas
et al., 2010). Yet, we note that the dynamic state of chromatin ar-
chitecture may influence absolute recombination frequency
(proximity of loxP sites). We also cannot exclude that the location
of the genomic recombination loci, and thus the size of resulting
recombinant sister chromatids, may influence segregation bias.
Such a hypothesis may be tested in the future by systematic
introduction of loxP sites at defined genomic distance intervals.
Our observation that distinct cell types show different YGRI for
the same chromosome could reflect a different recombination
activity of respective Cre drivers in a particular cellular lineage.
For our MADM-based analysis, we used Emx1- and Nestin-Cre
drivers that are mostly active in dividing neural stem cells and
turned off in postmitotic cells. The contribution of G0 recombina-
tion is thus expected to be minimal. Still, all YGRIs in neural lin-
eages were R1, with some up to an order of magnitude higher
indicating increasing rates of G2-Z segregation. However, a
certain rate of G1 recombination (also producing yellow cells
that increase the YGRI) besides G2-Z segregation may add to
the overall YGRI. Although G1 recombination events did not
occur in cultured ESCs (Liu et al., 2002; Armakolas and Klar
2006), we cannot currently exclude that interchromosomal
recombination efficiency could be distinct in G1 versus G2
phases of the cell cycle for different cell types in vivo. However,
for any given cell division cycle, the relative recombination
events in G1 versus G2 should be the same. Thus, different
YGRIs for different chromosomes must reflect chromosome-
specific sister chromatid segregation patterns in genetically
identical cells (here, Emx1+ cortical projection neurons). Perhaps
most striking was the finding that YGRIs of 10 different chromo-
somes in astrocytes were rather constant and low, indicating ar chromatid segregation patterns for all MADM reporters in cortical
w, GFP/tdT) in cerebral cortex in three exemplary MADM lines in combination
-17GT/TG;Emx1Cre/+; (bottom) MADM-19GT/TG;Emx1Cre/+. Scale bar: 100 mm.
ate (25–100 cells/mm3). (Bottom) Dense (>100 cells/mm3). Bars represent mean
M18 (n = 6); M4 and M6 (n = 8), and M1 (n = 12 mice).
mediated interchromosomal recombination at the loxP site in the MADM cas-
ate together to the same daughter cell (G2-Z segregation; yellow, GFP/tdT and
hter cells (G2-X segregation; green, GFP+ and red tdT+ cell, respectively) upon
m the number of yellow cells divided by the average of green and red cells to
w) and an (invisible) unlabeled cell. Note that yellow cells emerging from G1/G0
21 neocortex of all 19 MADM reporter lines in combination with the Emx1-Cre
do not correlate with the sizes of the respective MADM chromosomes. Bars
M6 (n = 8); and M1 (n = 12). (Bottom) YGRI ranking in correlation (red line) to
recombination frequency do not necessarily present high YGRI and vice versa.
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OPEN ACCESSuniformly high relative frequency for G2-X events in astrocyte
progenitors, which is in stark contrast to the values for the
same chromosomes in projection neurons that emerge also
from the same (Emx1+) stem cell lineage. Thus, sister chromatid
segregation appears highly biased in a chromosome-specific
manner in mitotic cortical Emx1+ progenitors. Furthermore, the
rank orders of YGRI for each chromosome in different cell types
were not the same, suggesting that the bias of sister chromatid
segregation patterns results from a complex combination of
chromosome and cell-type-specific mechanisms (Figure 7,
right).
Previous studies found that cultured ESC clones that were
differentiated into an neuroectoderm lineage never showed
G2-X segregation (Liu et al., 2002; Armakolas and Klar
2006). These findings are in stark contrast to our in vivo results
that demonstrate for all 19 mouse autosomes a substantial
amount of G2-X segregation in at least 4 distinct neural cell
lineages. Furthermore, our analysis of Dnah11 indicates that
the involved molecular mechanisms likely differ (at least for
chr7) when comparing cell culture to intact brain tissue. We
cannot fully explain the cause of the differences in results
obtained in cell culture and in vivo, but systemic and/or tis-
sue-wide acting mechanisms could be involved (Knouse
et al., 2018).
The phenomenon of biased sister chromatid segregation ap-
pears to be evolutionarily conserved (Pimpinelli and Ripoll
1986; Beumer et al., 1998). In asymmetrically dividing male
germline stem cells in Drosophila, sister chromatids of X and Y,
but not autosomes, are segregated non-randomly (Yadlapalli
and Yamashita 2013). In such a context, SUN-KASH proteins,
proposed to anchor sister chromatids to the centrosome,
seem to be involved, besides regulators of DNAmethylation (Ya-
dlapalli and Yamashita 2013). Although the underlying molecular
mechanismsmay or may not be conserved, it will be intriguing to
assess the physiological function in future studies and experi-
mentally approach the hypothesis postulating that biased sister
chromatid segregation could be a mechanism to instruct the cell
fate of nascent daughter cells during asymmetric stem cell divi-
sion (Bell 2005; Armakolas et al., 2010; Yadlapalli and Yamashita
2013). Because MADM enables both clonal lineage tracing withFigure 6. Sister chromatid segregation patterns based on YGRI in Dna
(A) (Left) Summary of YGRI analysis in selected MADM reporters with Dnah11 d
neocortex inMADM-7, MADM-12, andMADM-18 reporter lines in combination wi
of YGRI to 1 would indicate random sister chromatid segregation but that the YGR
show n = 3 mice for each genotype.
(B) Representative confocal microscopy images at P21 with MADM labeling (GFP
Cre (cerebellum) or Emx1-Cre (cerebral cortex and hippocampal CA1 area) drive
(Pcs), cortical pyramidal neurons (Pys), and CA1 pyramidal neurons (CA1 Pys). S
(C) YGRI for selectedMADM reporters in different neuronal lineages at P21. YGRI o
progenitors and cerebellar Purkinje cells derived from Nestin+ progenitors sign
chromosomes analyzed. Values represent mean ± SEM. Data show pyramidal ne
M11,M12,M16,M18, andM19 (n = 6); M10 (n = 7); M17 (n = 8); cerebellar Purkinje
and M5 (n = 6 mice).
(D) (Left) White blood cell preparations from spleen in MADM reporters with Hprt-
yellow GFP+/tdT+ CD3+ T cells (black) and CD19+ B cells (blue) were quantified. (
intermediate (MADM-8, MADM-15, and MADM-17), and dense (MADM-18 and
distinct YGRI but YGRI for T cells and B cells was not significantly different for all M
M18 (n = 3); M4, M17, and M19 (n = 4); M15 (n = 5 mice). Welch’s unequal varian
pM18 = 9.8E01, pM19 = 5.0E01.concurrent genetic manipulation, such an approach promises
high potential to systematically address the physiological role
of biased sister chromatid segregation in the future.
Genome-wideMADMmice library for single-cell genetic
mosaic analysis
Genetic dissection of cell-autonomous gene function
and system-wide effects
The MADM technology enables a variety of genetic in vivo
paradigms to study a broad spectrum of cell and developmental
processes (Zong et al., 2005; Luo 2007; Muzumdar et al., 2007;
Hippenmeyer 2013; Hippenmeyer et al., 2013). One exclusive
application of the MADM system is the feature enabling the ge-
netic dissection of the relative contributions of cell-autonomous
and extrinsic systemic and/or tissue-wide components to the
overall cellular phenotype upon the loss of candidate gene func-
tion (Hansen and Hippenmeyer 2020). In fact, single-cell pheno-
types in classical conditional or full knockout mutants often
reflect a combination of both cell-autonomous gene function
and environment-derived cues that may remedy or exacerbate
any observed phenotype. It is thus important to qualitatively
and quantitatively determine the relative contribution of the
intrinsic and extrinsic components to the overall loss of the
gene function phenotype. To this end, the MADM system
offers an unmatched experimental solution. The candidate
gene function can be either ablated in a very sparse mosaic (or
single clones) or tissue wide in all cells. Yet, in both paradigms,
single-cell MADM labeling enables the high-resolution quantita-
tive phenotypic analysis (Joo et al., 2014; Beattie et al., 2017;
Laukoter et al., 2020b; Takeo et al., 2021). The MADM lines
in conjunction with the above paradigms thus potentially permit
the systematic dissection of the level of cell autonomy of any
gene function in a given tissue, provided appropriate Cre driver
lines exist. Insights at the single-cell resolution as obtained
from MADM-based approaches in combination with systematic
candidate gene interrogation (Beattie et al., 2017; Laukoter et al.,
2020b) likely will have implications for our general understanding
of diseases including neurodevelopmental disorders (D’Gama
and Walsh 2018; Jayaraman et al., 2018; Buchsbaum and Cap-
pello 2019; Pinson et al., 2019; Subramanian et al., 2020).h11 knockout (KO) and in different somatic cell lineages
epletion (in iv mice). (Right) YGR index for cortical projection neurons in P21
th the Emx1-Cre driver in control andDnah11KO (iv) mice. Note that a decrease
I was not decreased uponDnah11mutation. Bars represent mean ±SEM. Data
, green; tdT, red) from selected MADM reporters in combination with a Nestin-
r used for quantifications in Figures 5C and 6A. Arrows indicate Purkinje cells
cale bar: 100 mm.
f cortical astrocytes and hippocampal CA1 pyramidal cells derived from Emx1+
ificantly differ from the YGRI of cortical pyramidal neurons for most MADM
urons (n = 6); cortical astrocytes (n = 6); CA1 pyramidal neurons M5, M7, M8,
cells M7,M8,M11,M16,M17, andM19 (n = 3); M12 andM18 (n = 4); M10 (n = 5)
Cre at P21 were subjected to FACS. The number of green GFP+, red tdT+, and
Right) YGRI for six different MADM chromosomes including sparse (MADM-4),
MADM-19) lines. The different MADM recombinant chromosomes displayed
ADMchromosomes analyzed. Bars represent mean ±SEM. Data showM8 and
ces t test, pM4 = 7.5E01, pM8 = 7.9E01, pM15 = 7.7E01, pM17 = 6.4E01,
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Figure 7. Models of biased sister chromatid segregation patterns in ESCs in vitro and in mouse in vivo
(Left) Previous studies (Liu et al., 2002; Armakolas and Klar 2006) using mitotic recombination and in combination with restriction-site sensitivity for genotyping in
ESC cultures reported that in ESC-derived neuroectodermal lineages no G2-X (recombinant chromosomes segregate away from each other during cell division)
events could be observed. In contrast, lineages derived from endodermal stem cells showed exclusively G2-X segregation patterns. Based on these findings, it
could be anticipated that inMADM therewould be no red and green cells in neural lineages (e.g., in the brain), whichwas not the case for all MADMchromosomes.
(Right) In vivo analysis of the prevalence of G2-X events (red and green cells) in comparison with total number of yellow cells (G2-Z, G1, and G0 events) for all
MADM chromosomes and in several somatic cell lineages revealed a significant bias in the recombinant chromosome and thus sister chromatid segregation
patterns. The segregation bias showed marked chromosome specificity that was distinct for different chromosomes in the same cell type in both brain and




OPEN ACCESSSingle-cell analysis of imprinting phenotypes in UPD
One MADM application includes the property to generate cells
with UPD and thus enable the study of imprinting phenotypes
at a single-cell level (Hippenmeyer et al., 2013; Laukoter et al.,
2020a, 2020c). In fact, technical limitations so far only allowed
the investigation of UPD at the whole-animal level but lacked
the resolution to obtain insights at the cellular level (Pauler
et al., 2021). It will be revealing in future studies to systematically
probe the cell-autonomous consequences of UPD at a single-
cell level and without inducing global changes in imprinted
gene expression affecting the whole animal. The library of all
19 MADM reporters will in principle enable the systematic anal-
ysis of UPD-associated cellular phenotypes in any organ, tissue,
and cell type in the mouse. Importantly, the analysis of candi-
date gene function, i.e., loss-of-function phenotypes, can be
separated from UPD-mediated imprinting phenotypes by
reverse MADM breeding schemes (Hippenmeyer et al., 2010,
2013; Joo et al., 2014; Beattie et al., 2017; Laukoter et al.,
2020b).14 Cell Reports 35, 109274, June 22, 2021One possible limitation or confounder for the interpretation of
MADM-based cell labeling and gene dosage is cellular poly-
ploidy (Øvrebø and Edgar 2018). It will thus be crucial in the
future to carefully analyze in organs with polyploid cells (1)
whethermore than one individual recombination event can occur
and (2) at which frequency. Depending on the probability of mul-
tiple recombination events, the color/tone of the overall MADM
labeling, and thus gene dosage, could be distinct from the above
predicted scenario for UPD and potentially offer an assay for
studying gene dosage across multiple scales. In a broader
context, because UPD in humans is associated with a variety
of diseases (Feinberg 2007; Tuna et al., 2009; Yamazawa
et al., 2010; Buiting et al., 2016) MADM-based analysis will
also contribute to our general understanding of the underlying
etiology of imprinting disorders at the single-cell level.
Analysis of cellular competition at single-cell level in
health and disease
MADM can be exploited for the study of cellular competition in a
developmental context (Joo et al., 2014; Takeo et al., 2021). For
Resource
ll
OPEN ACCESSinstance, when the TrkC neurotrophin receptor is removed
sparsely with MADM from just a few individual Purkinje cells in
the cerebellum, their dendrites have fewer and shorter branches.
In contrast, when TrkC is ablated from all Purkinje cells, the
dendrite trees look normal. Thus, a competitive mechanism
could be involved whereby the shape of the dendrite tree
depends on relative differences in neurotrophin/TrkC signaling
between Purkinje cell neighbors (Joo et al., 2014). Purkinje cell
dendritic arbors have also been shown to depend on GluD2-
and Cbln1-mediated competitive interactions (Takeo et al.,
2021). Cell competition has not only been implicated in cell
morphogenesis but also extensively studied in a variety of
contexts. Cell competition is particularly critical for overall tissue
homeostasis during growth and regeneration but also for cell
mixing and tissue invasion in cancer (Merino et al., 2016; Brás-
Pereira and Moreno 2018; Madan et al., 2018; Ellis et al.,
2019). With the availability of MADM for all mouse autosomes,
the phenomenon of cell competition can be studied holistically
and for virtually any candidate gene function associated with it
in diverse biological contexts in health and disease.
AlthoughMADM technology is versatile and offers multiple ap-
plications (discussed above), the method also has certain limita-
tions and alternative systems may be considered depending on
the biological question and context (Garcia-Gonzalez et al.,
2020; Hansen and Hippenmeyer 2020). For instance, the expres-
sion of the twomarkers relies on a single-copy insertion and thus
the expression level may be lower than, for example, that in viral-
based systems. Optimization of the MADM reporter expression
by using amplification systems such as, for example, the TIGRE
(Madisen et al., 2015; Daigle et al., 2018) might offer a solution.
Unlike TIGRE-based systems, MADM currently cannot be used
tomonitor physiological processes, but creating split transgenes
of diverse reporters in future could enable such applications in
clonally related cells in wild-type and potentially in a mutant
context. Although MADM can be used in combination with tem-
poral TM/CreER induction to label individual clones emerging
from dividing stem cells, the system cannot be used to sparsely
label and genetically manipulate postmitotic cells. Also, MADM
currently cannot be easily used for the overexpression of trans-
genes in a mosaic setting. However, a number of recently
developed systems—such as MASTR (Lao et al., 2012), Dual
ifgMosaic (Pontes-Quero et al., 2017), iSuRe-Cre (Fernández-
Chacón et al., 2019), MADR (Kim et al., 2019), or BATTLE
(Kohara et al., 2020) among others—allow for sparse and tunable
mosaic labeling and/or genetic manipulation including overex-
pression of transgenes in postmitotic cells in a variety of cellular
contexts. However, a clear advantage over the above methods
and special property of MADM relies on the built-in control
with two distinct fluorescent colors for mutant analysis and the
functional assessment of gene dosage. Thus, MADM can be
used for unparalleled comparative mutant versus heterozygote
and control analysis at once and at a single-cell resolution in
any given tissue in situ.
Lastly, MADM technology based on gene targeting in ESCs is
currently available only in mice. Future expansion of the system
to other species by endonuclease-mediated transgenesis like
CRISPR-Cas9 technology can be anticipated. Altogether, the
genome-wide MADM resource presented in this study likelywill catalyze the genetic dissection of cell-autonomous gene
function and thus molecular mechanisms with single-cell resolu-
tion across a broad spectrum of biological questions in health
and disease.
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MADM-4-TG targeting vector This study N/A
MADM-5-GT targeting vector This study N/A
MADM-5-TG targeting vector This study N/A
MADM-6-GT targeting vector This study N/A
MADM-6-TG targeting vector This study N/A
MADM-8-GT targeting vector This study N/A
MADM-8-TG targeting vector This study N/A
MADM-9-GT targeting vector This study N/A
MADM-9-TG targeting vector This study N/A
(Continued on next page)
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MADM-10-GT targeting vector This study N/A
MADM-10-TG targeting vector This study N/A
MADM-13-GT targeting vector This study N/A
MADM-13-TG targeting vector This study N/A
MADM-14-GT targeting vector This study N/A
MADM-14-TG targeting vector This study N/A
MADM-15-GT targeting vector This study N/A
MADM-15-TG targeting vector This study N/A
MADM-16-GT targeting vector This study N/A
MADM-16-TG targeting vector This study N/A
MADM-17-GT targeting vector This study N/A
MADM-17-TG targeting vector This study N/A
MADM-18-GT targeting vector This study N/A
MADM-18-TG targeting vector This study N/A
MADM-19-GT targeting vector This study N/A
MADM-19-TG targeting vector This study N/A
Oligonucleotides
See Table S2 N/A
Experimental Models: Cell Lines




Mouse: MADM-1-GT This study N/A
Mouse: MADM-1-TG This study N/A
Mouse: MADM-2-GT This study N/A
Mouse: MADM-2-TG This study N/A
Mouse: MADM-3-GT This study N/A
Mouse: MADM-3-TG This study N/A
Mouse: MADM-4-GT This study N/A
Mouse: MADM-4-TG This study N/A
Mouse: MADM-5-GT This study N/A
Mouse: MADM-5-TG This study N/A
Mouse: MADM-6-GT This study N/A
Mouse: MADM-6-TG This study N/A
Mouse: MADM-7-GT The Jackson Laboratory RRID:IMSR_JAX:021457
Mouse: MADM-7-TG The Jackson Laboratory RRID:IMSR_JAX:021458
Mouse: MADM-8-GT This study N/A
Mouse: MADM-8-TG This study N/A
Mouse: MADM-9-GT This study N/A
Mouse: MADM-9-TG This study N/A
Mouse: MADM-10-GT This study N/A
Mouse: MADM-10-TG This study N/A
Mouse: MADM-11-GT The Jackson Laboratory RRID:IMSR_JAX:013749
Mouse: MADM-11-TG The Jackson Laboratory RRID:IMSR_JAX:013751
Mouse: MADM-12-GT The Jackson Laboratory RRID:IMSR_JAX:021460
Mouse: MADM-12-TG The Jackson Laboratory RRID:IMSR_JAX:021461
Mouse: MADM-13-GT This study N/A
Mouse: MADM-13-TG This study N/A
(Continued on next page)
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Mouse: MADM-14-GT This study N/A
Mouse: MADM-14-TG This study N/A
Mouse: MADM-15-GT This study N/A
Mouse: MADM-15-TG This study N/A
Mouse: MADM-16-GT This study N/A
Mouse: MADM-16-TG This study N/A
Mouse: MADM-17-GT This study N/A
Mouse: MADM-17-TG This study N/A
Mouse: MADM-18-GT This study N/A
Mouse: MADM-18-TG This study N/A
Mouse: MADM-19-GT This study N/A
Mouse: MADM-19-TG This study N/A
Mouse: Emx1-Cre The Jackson Laboratory RRID:IMSR_JAX:005628
Mouse: Hprt-Cre The Jackson Laboratory RRID:IMSR_JAX:004302
Mouse: Nestin-Cre Petersen et al. 2002 N/A
Mouse: Apc-flox The Jackson Laboratory RRID:IMSR_JAX:009045
Mouse: iv mutant (Dnah11 mutant) The Jackson Laboratory RRID:IMSR_JAX:001045
Software and Algorithms
ZEN Digital Imaging for Light Microscopy Zeiss http://www.zeiss.com/microscopy/en_us/
products/microscope-software/zen.html#
introduction
FACS Diva BD Biosciences N/A
Graphpad Prism 8.0 Graphpad https://www.graphpad.com/scientific-software/prism/






FACS Aria III BD Biosciences N/A
LSM 800 Confocal Zeiss N/A
SlideScanner VS120 Olympus N/A
Cryostat Cryostar NX70 Thermo Fisher Scientific N/A





Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Simon
Hippenmeyer (simon.hippenmeyer@ist.ac.at).
Materials availability
All published and inaugural reported reagents and mouse lines will be shared upon request within the limits of the respective
material transfer agreements. All MADM lines will be made publicly available through The European Mouse Mutant Archive
(EMMA) and distributed from the University of Veterinary Medicine in Vienna or the Institute of Science and Technology Austria in
Klosterneuburg.
Data and code availability
This study did not generate code and all data have been presented in Figures and Supplemental Figures. Original imageswill bemade
available upon request.Cell Reports 35, 109274, June 22, 2021 e3
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Generation, breeding and husbandry of mouse lines
Experimental procedures were discussed and approved by the institutional ethics and animal welfare committees at IST Austria,
Stanford University, and at University of Veterinary Medicine Vienna in accordance with good scientific practice guidelines and na-
tional legislation (license number: IST Austria: BMWF-66.018/0007-II/3b/2012 and BMWFW-66.018/0006-WF/V/3b/2017; University
of Veterinary Medicine Vienna: BMWF-68.205/0023-II/3b/2014 and BMBWF-68.205/0010-V/3b/2019). Mice with specific pathogen
free status according to FELASA recommendations (Mähler Convenor et al., 2014) were bred and maintained in experimental rodent
facilities (room temperature 21 ± 1C [mean ± SEM]; relative humidity 40%–55%; photoperiod 12L:12D). Food (V1126, Ssniff Spe-
zialitäten GmbH, Soest, Germany) and tap water were available ad libitum.
Mouse lines with MADM cassettes inserted in Chr. 7 (Hippenmeyer et al., 2013), Chr. 11 (Hippenmeyer et al., 2010), and Chr. 12
(Hippenmeyer et al., 2013), Emx1-Cre (Gorski et al., 2003), Nestin-Cre (Petersen et al., 2002), Hprt-Cre (Tang et al., 2002), Apc-flox
(Cheung et al., 2010), and ivmice [Dnah11mutation (Hummel and Chapman 1959)] have been described previously.Nestin-Cre mice
were a kind gift fromW. Zhong. Bodyweight and signs of anemiawere evaluated for geneticmosaicMADM-18GT/TG;Apc;HprtCre/+ and
correspondingMADM-18GT/TG;HprtCre/+ control mice once per week. All analyses were carried out in mixed genetic background. The
two lines of each chromosome, with the exception of Chr. 7, 11 and 12, were designated as C57BL/6N;CD1-MADM-GTtm1(Chr1)Biat
and C57BL/6N;CD1-MADM-TGtm1(Chr1)Biat, as indicated here for Chr. 1. No sex specific differences were observed under any exper-
imental conditions or in any genotype.
METHOD DETAILS
Molecular biology
Generation of MADM targeting constructs
Molecular cloning and generation of recombinant DNA to construct all plasmids (incl. targeting vectors, plasmids with southern
probes etc.), and all nucleic acid procedures as described below were carried out according to standard cloning protocols (Sam-
brook et al., 1989).
Genomic DNA isolation from mouse ES cells
Mouse ES cells were lysed in Lysis Buffer (1M Tris-HCl pH = 7.5, 0.5M EDTA, 5M NaCl, 20% Sarcosyl, 20 mg/ml Proteinase K) over-
night at 55C. Next day, DNA was precipitated with isopropanol for 2 hr at room temperature with agitation and then carefully trans-
ferred into a fresh tube containing TE-buffer. The tubes were left open for 10min to allow residual isopropanol to evaporate. DNAwas
then incubated for 3 hr at 37C.
Southern blot
DIG-labeled probes were generated via PCR amplification of plasmid templates containing the probe sequence using a mix of
nucleotides containing Digoxigenin-11-dUTP (DIG-dUTP). The PCR reaction was next separated by electrophoresis and the corre-
sponding band was cut and gel purified using the Monarch DNA gel extraction Kit-NEB.
Genomic DNAwas digested with the corresponding enzymes overnight at 37C and electrophoresed in 0.8% agarose gels for 6 hr
at low voltage together with Lambda Hind III marker. Next day, the agarose gels were depurinized in 0.25M HCl, denaturated in 0.4
NaOH and transferred overnight into a positively charged nylon membrane. Next day, agarose gels were assessed under UV light to
verify complete transfer of DNA to the membrane. The nylon membrane was then neutralized in 0.5M Tris-HCl (pH = 7.5) and cross-
linked with UV light. The membrane was incubated in hybridization buffer (5x SSC, 2% Blocking reagent, 50% Formamide, 0.1%
Sarcosyl, 0.02% SDS) for 4 hr at 42C in glass tubes in a rotating oven. In the meantime, the DIG-labeled probe was denaturated
at 95C for 10min and then quickly chilled on ice for 5min. The DIG-labeled probe in Hybridization buffer was added to themembrane
and incubated overnight at 42C in glass tubes in a rotating oven. Next day, stringency washes were performed with Wash Solution I
(2xSSC, 0.1% SDS) at room temperature, followed byWash Solution II (0.2x SSC, 0.1% SDS) at 68C. Next day, the membrane was
blocked in blocking solution (1% blocking reagent, 0.1M Maleic acid, 0.15M NaCl) for 1 hr. Then anti-DIG AP antibody (1:20,000) in
Blocking Solution was added to the membrane, incubated for 30 min at room temperature and then washed with Wash buffer (0.1M
Maleic acid, 0.15M NaCl, 0.3% Tween) for 15 min. Finally, the membrane was incubated with CDP-Star (1:100) chemiluminescent
substrate in CDP-Star detection buffer (0.1M Tris-HCl, 0.1M NaCl, pH = 9.5) for 5 min, wrapped in transparent film and kept in
the dark for 1 hr. The pattern of probe hybridization was detected in a Peqlab FUSION SL Advance system for chemiluminescent
imaging.
Generation of transgenic MADM mice
Targeting of MADM constructs to mouse ES cells by electroporation
The linearized MADM targeting constructs were introduced into C57BL/6N embryonic stem cells (Parental ES cell line C2, Stock
Number: 011989-MU, Citation ID: RRID: MMRRC_011989-MU, A. Nagy Basic ES Cell line) by electroporation using a Bio-Rad
Gene Pulser Xcell. After selection with 150mg/ml G418, surviving clones were analyzed for correct targeted integration by Southern
blot hybridization (see above). Metaphase spread chromosome counting was performed on ES cells of clones with confirmed correct
targeting of the MADM cassettes before they were prepared for blastocyst injection.e4 Cell Reports 35, 109274, June 22, 2021
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Host blastocysts were produced by superovulation of BALB/cRj females by intraperitoneal (IP) injection with 5.0 IU of equine cho-
rionic gonadotropin (Folligon; Intervet) and, 48 hr later, with 5.0 IU of human chorionic gonadotropin (Chorulon; Intervet) followed
by mating with males of the same strain. Morula stages were harvested from isolated oviducts at day 2.5 days post coitum (dpc)
and cultured in M16 medium overnight in an incubator at 37C and 5% CO2 to produce host blastocysts. About 10-15 ES cells
were injected into a single blastocyst. The injected embryos were cultured for 2-3 hr to recover and then transferred into the right
uterus horn of 2.5 dpc pseudopregnant RjOrl:Swiss surrogate mothers as described earlier in detail (R€ulicke 2004, R€ulicke et al.,
2006). The offspring were selected based on their chimeric coat color. High-percentage male chimeras (> 80%) were bred with
C57BL/6NRj females and the offspring were selected by coat color and genotyped by PCR for the respective GT or TG MADM
transgenes.
Genotyping of MADM reporters, Apc-flox and iv mice
For primer sequences see Table S2. Forward and reverse primer 1 is specific for eachMADM reporter. In the absence of MADM cas-
settes the forward/reverse primer 1 PCR will result in the WT band as indicated. The reverse primer 2 is generic and located in the
MADMcassette. The forward/reverse primer 2 PCRwill result in theMADMband as indicated. The combined use of all three (forward,
reverse primer 1, and reverse primer 2) in a single PCR reactionwill enable the distinction ofWT (single band atWT size), heterozygote
(two bands, one at WT and one at MADM size), and homozygous MADM (single band at MADM size) stock mice. Note that
MADMGT/GT and MADMTG/TG stock mice should be maintained individually. The distinction of MADM-GT versus MADM-TG is
possible by using GT-cassette (GT-for and GT-rev) and TG-cassette (TG for and TG rev) specific primers, respectively. Male mice
can be identified by using Y chromosome (Ychrom for and Ychrom rev) specific primers. Presence of transgenes encoding Cre re-
combinase can be confirmed by using Cre primers (Cre for and Cre rev) as indicated.
Genotyping of Apc-flox mice was performed according to the protocol available at JAX. Genotyping of iv mice was performed
using TaKaRa PCR Amplification Kit followed by a 16h enzymatic digestion using TaKaRa TaqI at 65C. Separation of wt (50bp)
and mutant (100bp) band was performed on a 6% agarose gel.
Isolation of MADM-labeled tissue
Mice were deeply anesthetized through injection of ketamine/xylazine/acepromazine solution (65 mg, 13 mg and 2 mg/kg body
weight, respectively), and confirmed to be unresponsive through pinching the paw. Perfusion was performed with PBS followed
by ice-cold 4% PFA. Tissue was further fixed in 4% PFA overnight at 4C. Brain, thymus, heart, lung, liver, kidney, spleen, eye
and spinal cord were surgically removed and cryopreserved in 30% sucrose for 48 hr and then embedded in Tissue-Tek O.C.T.
(Sakura). All samples were stored at 20C or 80C until further usage. Samples were sectioned in a cryo microtome at a
10 mm (liver) or 45mm (all other samples) thickness. Brain samples were collected in 24 multi-well dishes and then mounted onto
Superfrost Glass Slides (Thermo Fisher Scientific), all other samples were directly mounted on glass slides.
For isolation of skin, pancreas, mammary gland intestine and colon, no perfusion was required. Mice were sacrificed by cervical
dislocation and back skin was prepared for histology as previously described (Amberg et al., 2015). Briefly, back skin was shaved and
surgically removed above the spine and placed on lint-free surface. Abdominal mammary glands, pancreas and small intestines were
surgically removed. Small intestines and colonswere cut open longitudinally andmade into Swiss rolls. All samples were incubated in
4% PFA at room temperature for 4hrs, then cryoprotected in 30% sucrose overnight at 4C and embedded into Tissue-Tek O.C.T.
(Sakura). All samples were stored at20C. Intestine samples from APCmice were sectioned at a 30mm thickness. All other samples
were sectioned at a 20mm thickness and directly mounted onto Superfrost Glass Slides (Thermo Fisher Scientific).
Histology and immunostaining of MADM-labeled tissue
For immunofluorescence staining in skin, pancreas, mammary gland and intestine, sections were thawed at room temperature for
15 min and encircled with DAKO hydrophobic pen. Then, they were washed 3x for 5 min with PBS. Antigen retrieval was performed
by adding pre-warmed citrate buffer pH = 6.0 to the samples and incubating them at 85C for 30 min. Samples were washed 3x for
5 min with PBS, then incubated in blocking solution (10% horse serum, 0.5% Triton X-100 in PBS) for 1h at room temperature. Pri-
mary antibodies were diluted in staining solution (5% horse serum, 0.5% Triton X-100 in PBS) and added to the samples over night at
4C. Next day, samples were washed 3x for 5min with PBS and incubated with secondary antibodies (1:1000) and Hoechst (Sigma,
1mg/ml stock, 1:1000) diluted in staining solution for 2hrs at room temperature. After washing 3x for 5min with PBS, samples were
mounted with Mowiol and stored at 4C until they were imaged at a Zeiss LSM800. Primary antibodies: Keratin 8 (Abcam, 1:100),
Keratin 14 (BioLegend, 1:500), beta-Catenin (Cell Signaling, 1:100), phospho-H3(Ser10) (Cell Signaling, 1:800). Secondary antibody:
donkey anti-rabbit Alexa647 (Molecular Probes). Mounted brain sections were washed 3x for 5 min in PBS, DAPI stained (1:20’000)
for 10 min and then embedded in mounting medium containing 1,4-diazabicyclooctane (DABCO; Roth) and Mowiol (Roth).
Flow cytometry
Mice were sacrificed by cervical dislocation and spleens were collected in ice-cold PBS. Spleens were minced through a 70mm cell
strainer. The strainers were then flushed with 10ml PBS-FBS (1x PBS, 2% FBS) and cell suspensions were centrifuged for 6min at
1,200rpm. Cell pellets were resuspended in 1ml ACK lysis buffer (GIBCO) and incubated for 30sec. Lysis reaction was stopped byCell Reports 35, 109274, June 22, 2021 e5
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5ml round-bottom FACS tubes via a 70mm cell strainer. Tubes were filled up with PBS-FBS and centrifuged for 6 min at 1,200 rpm.
Cells were incubated with Fc block (BD Biosciences) for 5 min and then incubated with 100ml of antibody mastermix for 30min on ice.
Antibodies CD3 HorizonV451 (eBioscience) and CD19 APC (eBioscience) were diluted 1:200. Finally, 4ml of PBS-FBS were added
and cells were centrifuged for 6 min at 1,200 rpm. Flow cytometric sorting of GFP+, tdT+ and GFP+ tdT+ cells was performed on a BD
AriaIII. Analysis was performed using FlowJo.
Analysis of MADM-labeled brains and peripheral tissue
Representative images were acquired at an inverted LSM800 or LSM880 confocal microscope (Zeiss) using 10X/20X objectives or
40X/63X oil objectives for acquisition of higher magnification images of immunostained tissue. Images where then processed using
Zeiss ZenBlue software and Photoshop (Adobe). Images for quantificationwere acquired at an inverted LSM800 or LSM880 confocal
microscope (Zeiss) or SlideScanner VS120 (Olympus) using 10X objective and processed via custom scripts in ImageJ. Tiled images,
encompassing the entire region of interest were imported into Photoshop software (Adobe) and the boundaries for the region of in-
terest were traced. MADM-labeled cells were manually counted based on respective marker expression.
Adenomas in MADM-18GT/TG;Apc;HprtCre/+ mice intestine or colon were classified based on pathological criteria described previ-
ously (Behrens et al., 1998; Fodde et al., 2001; Barker et al., 2009) such as nucleic dysplasia (enlarged and elongated nuclei, strong
nuclear staining), invasion of adenomatous epithelium into the lamina propria and up into the villus, coverage of adenomatous epithe-
lium by a normal surface mucosa, polypoid lesion morphology with depressed center, mitotic figures within the adenomatous
epithelium.
QUANTIFICATION AND STATISTICAL ANALYSIS
See Table S3 for complete information regarding quantifications and statistics used in this study. Table S3 includes all graphed
values, including SEMs, p values, and exact values of n. Statistical analysis was performed in the software Prism8 (GraphPad). Eval-
uation of data was performed by the Welch’s unequal variances t test (Figures 4, 5B, 6A, and 6D), Welch’s ANOVA (Figures 5E, 6C,
and 6D) or two-way ANOVA (Figure 6C). Data expressed as ratio was log-transformed prior to the statistical test. For Figures 4 and
5B, n was defined as the density of green/red cells per mm3 from one animal resulting from the quantification of 4-20 sections. For
Figures 5 and 6, nwas defined as the YGR index for one animal resulting from the quantification of 10-24 sections (Figures 5E, 6A, and
6C), or from FAC-sorted cells from one animal (Figure 6D). The YGRI was defined as the ratio of yellow cells divided by the average of
green and red cells.e6 Cell Reports 35, 109274, June 22, 2021
